Cited by 66Alzheimer's disease research and treatmentsMemory and Neural MechanismsNeuroscience and Neuropharmacology Research

The DOI matches its Crossref record; 219 of the 219 references it cites were found in a registry or an index.

Hippocampal Deficits in Amyloid-β-Related Rodent Models of Alzheimer’s Disease

Open access
Vyas, Yukti, Montgomery, Johanna M., Cheyne, Juliette E.·2020·Frontiers in Neuroscience

Abstract

Alzheimer’s disease (AD) is a progressive neurodegenerative disease that is the most common cause of dementia. Symptoms of AD include memory loss, disorientation, mood and behaviour changes, confusion, unfounded suspicions, and eventually, difficulty speaking, swallowing and walking. These symptoms are caused by neuronal degeneration and cell loss that begins in the hippocampus, and later in disease progression spreads to the rest of the brain. While there are some medications that alleviate initial symptoms, there are currently no treatments that stop disease progression. Hippocampal deficits in rodent models of AD have revealed synaptic, behavioural and circuit-level defects. These changes in synaptic function, plasticity, neuronal excitability, brain connectivity, and excitation/inhibition imbalance all have profound effects on circuit function, which in turn could exacerbate disease progression. However, a major limitation in this field is the lack of data and consensus to completely understand hippocampal deficits in AD. With the increasing development of in vivo recording techniques in awake and freely moving animals, future studies will extend our current knowledge of the mechanisms underpinning how hippocampal function is altered in AD, and aid in progression of treatment strategies that prevent and/or delay AD symptoms.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/fnins.2020.00266

Cites

219 of 219 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Items 201–219 of 219

Flagged first, then by citations

Research works printed but not linked: 1

  1. 2018, World Alzheimer Reports | Alzheimer’s Disease International.

Cited by

Sorted by citations

See all 66

Metadata

Authors
Vyas, Y., Montgomery, J. M., & Cheyne, J. E.
Affiliations
University of Auckland (NZ)
Corresponding author
  • Montgomery, Johanna M.
  • Cheyne, Juliette E.
Venue
Frontiers in Neuroscience
Published
2020-04-07
Volume
14
Pages
266-266
ISSN
1662-453X (ISSN-L)
OpenAlex
W3015745164
Cited by
66
References
219
Citations by year
2026: 4 · 2025: 6 · 2024: 13 · 2023: 18 · 2022: 9 · 2021: 11 · 2020: 5
FWCI
1.37
Type
journal article
Language
en
Open access
Locations
  • Frontiers in Neuroscience (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • ResearchSpace (University of Auckland) (submittedVersion, cc-by)
Topics
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
  • Life Sciences › Neuroscience › Cognitive Neuroscience › Memory and Neural Mechanisms
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
Keywords
Alzheimer's disease, hippocampus, amyloid-beta, rodent models, synaptic dysfunction, synaptic plasticity, neuronal excitability, brain connectivity, excitatory-inhibitory imbalance, memory impairment, neurodegeneration

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review